• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·4578.T
Share

Otsuka Holdings Co., Ltd. Stocks

¥ 10220Last Updated 12.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

¥ 33.68B

¥ 10220
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

10.06.2025 17:46

Vera Therapeutics soars on positive test data, only to plunge after competitor trial

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Otsuka Holdings Co., Ltd. is a global enterprise with operations spanning pharmaceuticals, nutraceuticals, consumer products, and various other sectors. Its pharmaceutical division is dedicated to developing treatments for a wide array of conditions, including oncology, cardiovascular, renal, and digestive system disorders, as well as ophthalmic issues. This focus also extends to diagnostic solutions, intravenous preparations, and medical devices. The company's significant product offerings include EQUELLE, tailored for women's health and beauty; BODYMAINTÉ Jelly and Drink, formulated as conditioning food and liquid; the popular hydration beverage POCARI SWEAT; Calorie Mate, a nutritional supplement; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a common household antiseptic. Beyond these, Otsuka's diverse offerings encompass soft drinks, various food products, and wines. The company is involved in the production of chemicals, including pharmaceutical intermediates, industrial chemicals, hydrazine, and specialized materials such as potassium titanate, polyolefin foams, and functional films, alongside stable isotopes. It provides clinical testing apparatus, medical equipment, analysis and measurement tools, and vehicle headlight testers. Furthermore, Otsuka's portfolio extends to cosmetics, warehousing and transport services, and advanced software for optimizing mental healthcare systems. Other products include synthetic resin molded items, paper goods, artificial turf, and a full spectrum of ceramic products—boards, walls, reliefs, terracotta, OT ceramics, portraits, and sign boards. Additionally, it offers spring and mineral water, insecticide and toiletry products, and adhesive tapes. Rounding out its operations, the company also manages a hotel. Established in 1921, Otsuka Holdings Co., Ltd. is headquartered in Tokyo, Japan.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, r

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 4578.T is 13166 and suggests 29% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 16:01

Highlights in small-caps: record IPO in biotech, Wizz Air success, SpaceX effect

13.06.2026 13:01

An investment idea for all times, IPO of the year and how to keep emotions in check in the stock market

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026